Form 4: Zimmer Biomet Director Louis Shapiro Reports Acquisition of Phantom Stock Units

Director Louis Shapiro reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.

Summary

• On December 31, 2024, Louis Shapiro, a director of Zimmer Biomet Holdings, Inc., acquired 130.048 phantom stock units under the company's Deferred Compensation Plan for Non-Employee Directors.
• These units are convertible to common stock on a 1-for-1 basis and will be settled within sixty days after Shapiro's service as a director ends.
• The price of the derivative security is $0.
• Following the transaction, Shapiro beneficially owns 1,108.416 phantom stock units, which includes 2.166 units accrued on October 31, 2024, through dividend reinvestment.
• The reporting was filed on January 3, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction related to director compensation. The acquisition of stock units can be seen as a positive sign, but it's not a major event.

Positives

• The acquisition of phantom stock units by a director signals confidence in the company's future performance.

Future Outlook

The phantom stock units will be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Industry Context

This filing is a routine disclosure related to executive compensation and is typical for publicly traded companies. It provides transparency into the holdings of company insiders.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.

Key Dates